TerminatedNCT02909504
Gao NARASD Lithium Study
Medication studyAges 18–70United StatesBipolarity
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateSeptember 2016
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 24
- Sponsor
- Keming Gao
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02909504
- Official title
Show the full official title
Biomarkers in Mononuclear Blood Cells for Lithium Treatment Response of Bipolar Disorder
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Keming Gao.
Does this study involve medication?
Yes. The study involves medication, including lithium.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.